Permian Basin Royalty Trust (PBT)

7.38
0.16 2.20
NYSE : Energy Minerals
Prev Close 7.22
Open 7.24
Day Low/High 7.24 / 7.41
52 Wk Low/High 5.52 / 10.30
Volume 92.23K
Avg Volume 105.20K
Exchange NYSE
Shares Outstanding 46.61M
Market Cap 343.97M
EPS 0.60
P/E Ratio 7.24
Div & Yield 0.60 (9.15%)

Latest News

Permian Basin Royalty Trust Announces January Cash Distribution

Permian Basin Royalty Trust Announces January Cash Distribution

DALLAS, Jan. 18, 2019 /PRNewswire/ -- Simmons Bank, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT) ("Permian") today declared a cash distribution to the holders of its units of beneficial interest of $0.

Life Biosciences LLC Leads Strategic Investment Of Up To A$44.5 Million (US$31.4 Million) In Prana

Life Biosciences LLC Leads Strategic Investment Of Up To A$44.5 Million (US$31.4 Million) In Prana

MELBOURNE, Australia and SAN FRANCISCO, Jan. 2,  2019 /PRNewswire/ -- Prana Biotechnology Ltd (ASX: PBT, NASDAQ: PRAN) ("Prana" or "the Company") has today announced that it has entered into a securities purchase agreement for a lead investment by Boston...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: None Downgrades: ABCB, ADSW, BY, CLGX, DSGX, IMO, JBT, KAMN, KBR, LBRDA, LBRDK, PBT, SF, WAL, WRD Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Permian Basin Royalty Trust Announces December Cash Distribution

Permian Basin Royalty Trust Announces December Cash Distribution

DALLAS, Dec. 20, 2018 /PRNewswire/ -- Simmons Bank, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT) ("Permian") today declared a cash distribution to the holders of its units of beneficial interest of $0.

Permian Basin Royalty Trust Enters Oversold Territory (PBT)

Permian Basin Royalty Trust Enters Oversold Territory (PBT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Permian Basin Royalty Trust Announces November Cash Distribution

Permian Basin Royalty Trust Announces November Cash Distribution

DALLAS, Nov. 19, 2018 /PRNewswire/ -- Simmons Bank, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT) ("Permian") today declared a cash distribution to the holders of its units of beneficial interest of $0.

RSI Alert: Permian Basin Royalty Trust (PBT) Now Oversold

RSI Alert: Permian Basin Royalty Trust (PBT) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Permian Basin Royalty Trust Announces October Cash Distribution

Permian Basin Royalty Trust Announces October Cash Distribution

DALLAS, Oct. 19, 2018 /PRNewswire/ -- Simmons Bank, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT) ("Permian") today declared a cash distribution to the holders of its units of beneficial interest of $0.

Prana Biotechnology: Pre-Clinical Evidence Demonstrates PBT434 As A Potential Treatment For MSA

Prana Biotechnology: Pre-Clinical Evidence Demonstrates PBT434 As A Potential Treatment For MSA

Prana Biotechnology Ltd (ASX: PBT) (NASDAQ: PRAN) today announced further pre-clinical evidence for PBT434 will be presented in a poster at the International Congress of Parkinson's Disease and Movement Disorders® in Hong Kong on Sunday, October 7 th,...

Permian Basin Royalty Trust Becomes Oversold

Permian Basin Royalty Trust Becomes Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Permian Basin Royalty Trust Announces September Cash Distribution

Permian Basin Royalty Trust Announces September Cash Distribution

DALLAS, Sept. 18, 2018 /PRNewswire/ -- Simmons Bank, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT) ("Permian") today declared a cash distribution to the holders of its units of beneficial interest of $0.

Permian Basin Royalty Trust Becomes Oversold (PBT)

Permian Basin Royalty Trust Becomes Oversold (PBT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Permian Basin Royalty Trust (PBT) Shares Cross Above 200 DMA

Permian Basin Royalty Trust (PBT) Shares Cross Above 200 DMA

In trading on Monday, shares of Permian Basin Royalty Trust crossed above their 200 day moving average of $9.36, changing hands as high as $9.40 per share. Permian Basin Royalty Trust shares are currently trading up about 1.6% on the day.

PBT434 Data To Be Presented At The International Congress Of Parkinson's Disease And Movement Disorders

PBT434 Data To Be Presented At The International Congress Of Parkinson's Disease And Movement Disorders

Prana Biotechnology Ltd (ASX PBT: NASDAQ PRAN) has today announced it will be presenting further pre-clinical evidence for PBT434 at the International Congress of Parkinson's Disease and Movement Disorders® to be held in Hong Kong from October 5-9, 2018.

First Volunteers Dosed In Phase I Clinical Trial Of PBT434, Prana's Lead Therapy For Parkinsonian Diseases

First Volunteers Dosed In Phase I Clinical Trial Of PBT434, Prana's Lead Therapy For Parkinsonian Diseases

Prana Biotechnology Ltd (ASX PBT: NASDAQ PRAN) is pleased to announce the first cohort of volunteers in its Phase I clinical trial have been administered PBT434, an experimental drug under investigation for the treatment of Parkinsonian diseases.

Prana To Commence Phase 1 Clinical Trial Of PBT434 For Treatment Of Parkinsonian Diseases

Prana To Commence Phase 1 Clinical Trial Of PBT434 For Treatment Of Parkinsonian Diseases

Prana Biotechnology Ltd (ASX PBT: NASDAQ PRAN) is pleased to announce it has received ethics committee approval and has commenced recruitment for its Phase I Clinical trial evaluating the safety, tolerability and pharmacokinetics of the Company's lead...

Oversold Conditions For Permian Basin Royalty Trust (PBT)

Oversold Conditions For Permian Basin Royalty Trust (PBT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: OZM, PBT, PFSW, SON, UBOH Downgrades: EBR, EBR.B, RECN, TA Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

PBT Ex-Dividend Reminder - 11/29/17

PBT Ex-Dividend Reminder - 11/29/17

Looking at the universe of stocks we cover at Dividend Channel, on 11/29/17, Permian Basin Royalty Trust will trade ex-dividend, for its monthly dividend of $0.0510, payable on 12/14/17. As a percentage of PBT's recent stock price of $9.19, this dividend works out to approximately 0.56%, so look for shares of Permian Basin Royalty Trust to trade 0.56% lower — all else being equal — when PBT shares open for trading on 11/29/17.

PBT Crosses Above Key Moving Average Level

PBT Crosses Above Key Moving Average Level

In trading on Friday, shares of Permian Basin Royalty Trust crossed above their 200 day moving average of $8.91, changing hands as high as $8.93 per share. Permian Basin Royalty Trust shares are currently trading up about 1.6% on the day.

Oversold Conditions For Permian Basin Royalty Trust (PBT)

Oversold Conditions For Permian Basin Royalty Trust (PBT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Prana Commences Research Collaboration With Takeda For The Treatment Of Parkinson's Disease Gastrointestinal Neuropathology

Prana Commences Research Collaboration With Takeda For The Treatment Of Parkinson's Disease Gastrointestinal Neuropathology

Prana Biotechnology Ltd (ASX:PBT)(NASDAQ:PRAN) today announced a research collaboration with Takeda Pharmaceuticals International, Inc.

Prana's PBT434 Lowers Alpha-Synuclein And Prevents Neurodegeneration

Prana's PBT434 Lowers Alpha-Synuclein And Prevents Neurodegeneration

Prana Biotechnology Ltd (NASDAQ: PRAN) (ASX: PBT) today announced the article " The novel compound PBT434 prevents iron-mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease" was...

Permian Basin Royalty Trust Enters Oversold Territory (PBT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Permian Basin Royalty Trust About To Put More Money In Your Pocket (PBT)

Looking at the universe of stocks we cover at Dividend Channel, on 3/29/17, Permian Basin Royalty Trust will trade ex-dividend, for its monthly dividend of $0.0472, payable on 4/13/17. As a percentage of PBT's recent stock price of $9.00, this dividend works out to approximately 0.52%, so look for shares of Permian Basin Royalty Trust to trade 0.52% lower — all else being equal — when PBT shares open for trading on 3/29/17.

Permian Basin Royalty Trust About To Put More Money In Your Pocket (PBT)

Permian Basin Royalty Trust About To Put More Money In Your Pocket (PBT)

Looking at the universe of stocks we cover at Dividend Channel, on 1/27/17, Permian Basin Royalty Trust will trade ex-dividend, for its monthly dividend of $0.0480, payable on 2/14/17. As a percentage of PBT's recent stock price of $8.77, this dividend works out to approximately 0.55%, so look for shares of Permian Basin Royalty Trust to trade 0.55% lower — all else being equal — when PBT shares open for trading on 1/27/17.

PBT Ex-Dividend Reminder - 10/27/16

PBT Ex-Dividend Reminder - 10/27/16

Looking at the universe of stocks we cover at Dividend Channel, on 10/27/16, Permian Basin Royalty Trust will trade ex-dividend, for its monthly dividend of $0.0471, payable on 11/15/16. As a percentage of PBT's recent stock price of $6.91, this dividend works out to approximately 0.68%, so look for shares of Permian Basin Royalty Trust to trade 0.68% lower — all else being equal — when PBT shares open for trading on 10/27/16.

TheStreet Quant Rating: C+ (Hold)